Breast cancer
Systemic therapy for early stage TNBCJamila (36 years old)
Jamila, 36 years old, works as an event manager. Her creativity and hands-on mentality allow her to organise the best team buildings, weddings and birthday parties. She recently felt a lump in the left breast.
Assessment summary
- Premenopausal
- No family history of breast and ovarian cancer
- No relevant medical history, ECOG PS: 0
- Tumour size: cT2 (33 mm), LN status: cN1
- Tumour biology:
- Ductal invasive carcinoma of NST
- ER 0%, PgR 0%, HER2 IHC 0
- Ki67 70%
- G3
- CT scan chest/abdomen and bone scan: no metastases
- Genetic testing: no BRCA1/2 mutation
- Primary systemic therapy (including LHRH analogue): 4 cycles of pembrolizumab + paclitaxel + carboplatin, followed by 4 cycles of pembrolizumab + AC
- BCS + SLNB
- Pathology report:
- Residual tumour: ductal invasive carcinoma of NST, ER 0%, PgR 0%, HER2/neu IHC 0, Ki67 20%
- Stage ypT1N0
- Residual cancer burden: RCB-II